399 related articles for article (PubMed ID: 34975915)
1. Computational Prediction of Biomarkers, Pathways, and New Target Drugs in the Pathogenesis of Immune-Based Diseases Regarding Kidney Transplantation Rejection.
Alfaro R; Martínez-Banaclocha H; Llorente S; Jimenez-Coll V; Galián JA; Botella C; Moya-Quiles MR; Parrado A; Muro-Perez M; Minguela A; Legaz I; Muro M
Front Immunol; 2021; 12():800968. PubMed ID: 34975915
[TBL] [Abstract][Full Text] [Related]
2. CCR7 and CD48 as Predicted Targets in Acute Rejection Related to M1 Macrophage after Pediatric Kidney Transplantation.
Zhang J; Pei J; Yu C; Luo J; Hong Y; Hua Y; Wei G
J Immunol Res; 2024; 2024():6908968. PubMed ID: 38957433
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial.
Eskandary F; Bond G; Schwaiger E; Kikic Z; Winzer C; Wahrmann M; Marinova L; Haslacher H; Regele H; Oberbauer R; Böhmig GA
Trials; 2014 Apr; 15():107. PubMed ID: 24708575
[TBL] [Abstract][Full Text] [Related]
4. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.
Sadaka B; Ejaz NS; Shields AR; Cardi MA; Wadih G; Witte D; Abu Jawdeh BG; Alloway RR; Woodle ES
Transplantation; 2015 Aug; 99(8):1691-9. PubMed ID: 25803498
[TBL] [Abstract][Full Text] [Related]
5. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
Yazdani S; Callemeyn J; Gazut S; Lerut E; de Loor H; Wevers M; Heylen L; Saison C; Koenig A; Thaunat O; Thorrez L; Kuypers D; Sprangers B; Noël LH; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
Kidney Int; 2019 Jan; 95(1):188-198. PubMed ID: 30396694
[TBL] [Abstract][Full Text] [Related]
7. Identification of Biomarkers for Predicting Allograft Rejection following Kidney Transplantation Based on the Weighted Gene Coexpression Network Analysis.
Wang LJ; Ma XB; Xia HY; Sun X; Yu L; Yang Q; Hu ZQ; Zhao YH; Hu W; Ran JH
Biomed Res Int; 2021; 2021():9933136. PubMed ID: 34368360
[TBL] [Abstract][Full Text] [Related]
8. CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection.
Doberer K; Kläger J; Gualdoni GA; Mayer KA; Eskandary F; Farkash EA; Agis H; Reiter T; Reindl-Schwaighofer R; Wahrmann M; Cohen G; Haslacher H; Bond G; Simonitsch-Klupp I; Halloran PF; Böhmig GA
Transplantation; 2021 Feb; 105(2):451-457. PubMed ID: 32235256
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood transcriptome analysis and development of classification model for diagnosing antibody-mediated rejection vs accommodation in ABO-incompatible kidney transplant.
Jeon HJ; Lee JG; Kim K; Jang JY; Han SW; Choi J; Ryu JH; Koo TY; Jeong JC; Lee JW; Ishida H; Park JB; Lee SH; Ahn C; Yang J
Am J Transplant; 2020 Jan; 20(1):112-124. PubMed ID: 31373158
[TBL] [Abstract][Full Text] [Related]
10. LCK as a Potential Therapeutic Target for Acute Rejection after Kidney Transplantation: A Bioinformatics Clue.
Jia L; Jia R; Li Y; Li X; Jia Q; Zhang H
J Immunol Res; 2018; 2018():6451298. PubMed ID: 29977931
[TBL] [Abstract][Full Text] [Related]
11. A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation.
Rascio F; Pontrelli P; Accetturo M; Oranger A; Gigante M; Castellano G; Gigante M; Zito A; Zaza G; Lupo A; Ranieri E; Stallone G; Gesualdo L; Grandaliano G
J Pathol; 2015 Sep; 237(1):72-84. PubMed ID: 25925804
[TBL] [Abstract][Full Text] [Related]
12. Use of Quantitative Real Time Polymerase Chain Reaction to Assess Gene Transcripts Associated With Antibody-Mediated Rejection of Kidney Transplants.
Dominy KM; Roufosse C; de Kort H; Willicombe M; Brookes P; Behmoaras JV; Petretto EG; Galliford J; Choi P; Taube D; Cook HT; Mclean AG
Transplantation; 2015 Sep; 99(9):1981-8. PubMed ID: 25675206
[TBL] [Abstract][Full Text] [Related]
13. Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis.
Heidari SS; Nafar M; Kalantari S; Tavilani H; Karimi J; Foster L; Moon KM; Khodadadi I
J Proteomics; 2021 May; 240():104208. PubMed ID: 33785428
[TBL] [Abstract][Full Text] [Related]
14. The impact of C4d staining as a humoral injury marker.
Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
[TBL] [Abstract][Full Text] [Related]
15. Allo-specific immune response profiles indicative of acute rejection in kidney allografts using an in vitro lymphocyte culture-based model.
Mahakur S; Saikia B; Minz M; Minz RW; Nada R; Anand S; Sharma A; Jha V; Joshi N; Goel L; Arora A; Joshi K
Clin Exp Nephrol; 2018 Apr; 22(2):465-473. PubMed ID: 28849286
[TBL] [Abstract][Full Text] [Related]
16. Urinary cell transcriptomics and acute rejection in human kidney allografts.
Verma A; Muthukumar T; Yang H; Lubetzky M; Cassidy MF; Lee JR; Dadhania DM; Snopkowski C; Shankaranarayanan D; Salvatore SP; Sharma VK; Xiang JZ; De Vlaminck I; Seshan SV; Mueller FB; Suhre K; Elemento O; Suthanthiran M
JCI Insight; 2020 Feb; 5(4):. PubMed ID: 32102984
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
Reese SR; Wilson NA; Huang G; Redfield RR; Zhong W; Djamali A
Transplantation; 2015 Sep; 99(9):1785-95. PubMed ID: 25919767
[TBL] [Abstract][Full Text] [Related]
18. An Integrated Transcriptomic Approach to Identify Molecular Markers of Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
Rhone ET; Bardhi E; Bontha SV; Walker PD; Almenara JA; Dumur CI; Cathro H; Maluf D; Mas V
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063776
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential key protein interaction networks of BK virus nephropathy in patients receiving kidney transplantation.
Jia L; Fu W; Jia R; Wu L; Li X; Jia Q; Zhang H
Sci Rep; 2018 Mar; 8(1):5017. PubMed ID: 29567951
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series.
De Sousa-Amorim E; Revuelta I; Diekmann F; Cofan F; Lozano M; Cid J; Palou E; Sole M; Campistol JM; Oppenheimer F
Nephrology (Carlton); 2016 Aug; 21(8):700-4. PubMed ID: 26492594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
